Endovaskulyarnye metody issledovaniya i lecheniya v kardiologii: vremya yubileev i somneniy


如何引用文章

全文:

详细

参考

  1. Бабунашвили А.М., Рабкин И.Х. Иванов В.А. Коронарная ангиопластика. М., 1996.
  2. Serruys PW, Luijten HE, Beatt KJ et al. Incidence of restenosis after successful coronary angioplasty: a time related phenomenon. Circulation 1988; 77: 361-71.
  3. Nobuyoshi M, Kimura T, Nosoka H et al. Restenosis after successful Percutaneous transluminal coronary angioplasty. Serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-23.
  4. Williams DO, Joelson JM, Most AS. Angiographic findings when chest pain recurs after successful percutaneous transluminal coronary angioplasty. Am J Cardiology 1987; 60: 792-5.
  5. Meier B. Use and Abuse of Coronary Stenting. Hospital Chronicles 2006; Suppl.: 99-103.
  6. Daemen J, Serruys PW. Drug-Eluting Stent Update 2007. Part I: A Survey of Current and Future Generation Drug-Eluting Stents: Meaningful Advances or More of the Same? Circulation 2007; 116: 316-28.
  7. Camenzind E. ESC Congress News 2006, September.
  8. Stone GW et al. New Engl J Med 2007; 356: 998-1008.
  9. Lagerqvist B, James SK et al. Long-term outcomes with drug eluting stents versus bare-metal stents in Sweden. New Engl J Med 2007; 356: 1009-19.
  10. Tu JV, Bowen J et al. Effectiveness and safety of drug-eluting stents in Ontario. New Engl J Med 2007; 357: 1393-402.
  11. Stettler C et al. Lancet 2007; 370: 937-48.
  12. Marroquin OC, Kip KE, Kelley DE et al. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation. Circulation 2004; 109: 714-21.
  13. Cutlip DE, Chauhan MS, Baim DS et al. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 2002; 40: 2082-9.
  14. Pache J, Kastrati A, Mehilli J et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 2003; 41: 1283-8.
  15. Piatti P, Di Mario C, Monti LD et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003; 108: 2074-81.
  16. Rana JS, Monraats PS et al. Metabolic Syndrome and Risk of Restenosis in Patients Undergoing Percutaneous Coronary Intervention.
  17. Detre KM et al. Circulation 1999; 99: 316-28.
  18. Bravata DM et al. Ann Intern Med 2007; 147.

补充文件

附件文件
动作
1. JATS XML
下载


Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 83918 от 12.09.2022 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 83917 от 12.09.2022 г.